Cancer Channel
Related Channels

Lazanda Dosage

Various factors will affect the amount of Lazanda your healthcare provider prescribes, such as other medications you are taking, your level of pain, and how you respond to Lazanda. The initial dosage for treating breakthrough cancer pain is usually 100 mcg, which is given as one spray into one nostril no more than four times a day.

An Introduction to Dosing With Lazanda

The dose of Lazanda® (fentanyl nasal spray) your healthcare provider recommends will vary, depending on a number of factors, including:
  • Your level of pain
  • How you respond to the medication
  • Other medications you are taking
  • Other medical conditions you may have.
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.

Initial Lazanda Dosage

The standard initial dosage of Lazanda for breakthrough pain is 100 mcg (given as one spray into one nostril) no more often than every two hours, for a maximum of four doses a day. If this dosage provides adequate pain relief within 30 minutes, it will be used for future episodes of breakthrough pain.
If the initial 100-mcg dosage does not provide adequate pain relief within 30 minutes, the amount will be slowly increased until an adequate amount is found or side effects become intolerable. Doses above 800 mcg have not been studied in clinical trials.
Your healthcare provider may need to periodically adjust your Lazanda dosage if your underlying pain level changes, your long-acting opioid dose changes, or you develop Lazanda side effects. It is important that you work closely with your healthcare provider throughout treatment to make sure you remain on the most appropriate dosage for your individual situation.
Lazanda must be given in addition to a regularly scheduled opioid narcotic for underlying, persistent pain. If you stop taking an opioid pain medication on a regular basis, you will also need to stop using Lazanda.
Warning: 10 Hidden Sources of Lactose

Lazanda Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.